000157213 001__ 157213
000157213 005__ 20240229123132.0
000157213 0247_ $$2doi$$a10.1007/s00228-020-02954-5
000157213 0247_ $$2pmid$$apmid:32648116
000157213 0247_ $$2ISSN$$a0031-6970
000157213 0247_ $$2ISSN$$a0369-9498
000157213 0247_ $$2ISSN$$a1432-1041
000157213 037__ $$aDKFZ-2020-01483
000157213 041__ $$aeng
000157213 082__ $$a610
000157213 1001_ $$0P:(DE-He78)abb10265fc5b7b424eee557e979d490f$$aNguyen, Mai Thi Ngoc$$b0$$eFirst author$$udkfz
000157213 245__ $$aPain severity and analgesics use in the community-dwelling older population: a drug utilization study from Germany.
000157213 260__ $$aNew York$$bSpringer$$c2020
000157213 3367_ $$2DRIVER$$aarticle
000157213 3367_ $$2DataCite$$aOutput Types/Journal article
000157213 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636705156_5415
000157213 3367_ $$2BibTeX$$aARTICLE
000157213 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000157213 3367_ $$00$$2EndNote$$aJournal Article
000157213 500__ $$a2020 Dec;76(12):1695-1707#EA:C070#LA:C070#
000157213 520__ $$aChronic pain is common in the older population and a significant public health concern. However, comprehensive studies on analgesics use in this age group from Germany are scarce. This study aims to give a comprehensive overview on the use of the most common therapeutic groups of analgesics in community-dwelling older adults from Germany.A cross-sectional study was carried out using data from a German cohort of 2038 community-dwelling adults aged 63-89 years. Descriptive statistics and logistic regression models were applied to assess the utilization of analgesics by age, sex, pain severity, pain duration, and locations.One out of four study participants was suffering from high-intensity or disabling pain. Approximately half of those taking analgesics still reported to suffer from high-intensity or disabling pain. Among analgesics users, occasional non-steroidal anti-inflammatory drugs (NSAIDs) use was the most frequent pain therapy (in 43.6% of users), followed by metamizole (dipyrone) use (16.1%), regular NSAIDs use (12.9%), strong opioids use (12.7%), and weak opioids use (12.0%). In multivariate logistic regression models, higher age, higher pain severity, longer pain duration, abdominal pain, and back pain were statistically significantly associated with opioids use. Metamizole use was also statistically significantly associated with higher pain severity but inversely associated with pain duration.A significant number of older German adults are affected by high-intensity and disabling chronic pain despite receiving analgesics. Long-term studies are needed to compare the effectiveness and safety of different treatments for chronic pain in older adults.
000157213 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000157213 588__ $$aDataset connected to CrossRef, PubMed,
000157213 7001_ $$0P:(DE-He78)358cd16fe1dd16be6e4eaf0e76e5ad57$$aLaetsch, Dana Clarissa$$b1$$udkfz
000157213 7001_ $$0P:(DE-He78)ad44271ecf6b1eec3e0d0089c66dfdbe$$aChen, Li-Ju$$b2$$udkfz
000157213 7001_ $$aHaefeli, Walter Emil$$b3
000157213 7001_ $$aMeid, Andreas D$$b4
000157213 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$udkfz
000157213 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b6$$eLast author$$udkfz
000157213 773__ $$0PERI:(DE-600)1459058-x$$a10.1007/s00228-020-02954-5$$n12$$p1695-1707$$tEuropean journal of clinical pharmacology$$v76$$x1432-1041$$y2020
000157213 909CO $$ooai:inrepo02.dkfz.de:157213$$pVDB
000157213 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)abb10265fc5b7b424eee557e979d490f$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000157213 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)358cd16fe1dd16be6e4eaf0e76e5ad57$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000157213 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ad44271ecf6b1eec3e0d0089c66dfdbe$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000157213 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000157213 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000157213 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000157213 9141_ $$y2020
000157213 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-01-24$$wger
000157213 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2020-01-24$$wger
000157213 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J CLIN PHARMACOL : 2018$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-01-24
000157213 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-24
000157213 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000157213 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000157213 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000157213 980__ $$ajournal
000157213 980__ $$aVDB
000157213 980__ $$aI:(DE-He78)C070-20160331
000157213 980__ $$aUNRESTRICTED